A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
This study has been completed.
First Posted: September 8, 2005
Last Update Posted: September 17, 2007
Information provided by:
The purpose of this study is to assess the safety of lanthanum carbonate in patients undergoing dialysis who have received lanthanum carbonate in the previous studies and wish to continue treatment.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
|Official Title:||A Long Term, Open Label Extension Study of Protocols LAM-IV-301, LAM-IV 303, LAM-IV 307 AND LAM-IV 308.|
Resource links provided by NLM:
Further study details as provided by Shire:
Primary Outcome Measures:
- Treatment emergent adverse events following up to 24 months of treatment
Secondary Outcome Measures:
- Changes in pre-dialysis serum phosphate levels
- Control of pre-dialysis serum phosphate levels
- Plasma lanthanum levels
|Study Start Date:||October 2002|
|Study Completion Date:||January 2006|
Contacts and Locations
No Contacts or Locations Provided